CompletedNot Applicable

The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS

Canada30 participantsStarted 1999-09

Plain-language summary

The main aim of the study is to investigate the combined effects of using anabolic steroids and protease inhibitors on fat metabolism and body composition of People Living with HIV/AIDS. We are seeking to answer the following questions: 1\) Are there any significant differences in serum blood lipids, lipodystrophy, in persons with HIV taking antiretroviral therapies and anabolic steroids versus antiretroviral therapies alone?

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * documented HIV seropositive status * 18 years of age or older * combination antiretroviral therapies for at least three months or more * able to comply with study procedures and protocol * signed informed consent Exclusion Criteria: * acute opportunistic infections at baseline * use of serum lipid lowering drugs * use of serum sugar controlling drugs * evidence of drug or alcohol use which may interfere with study participation * a recent illness with associate weight loss of greater than or equal to 10lbs

What they're measuring

differences in serum lipid levels

differences in regional and overall body fat level

impacts on metabolic and cardiovascular health

Trial details

NCT IDNCT00202241

SponsorQueen's University

Sponsor typeOTHER

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More HIV trials